VRDN VIRIDIAN THERAPEUTICS ORS
Health Care · Russell 2000
Next earnings: not announced yet
What 19 analyst firms say about VIRIDIAN THERAPEUTICS ORS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
17 rated views · 19 analyst/firm records · 19 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8063
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8070
Recent analyst activity · last 90 days
Our tracked history has 14 reports on VRDN from 10 analyst firms in the last 90 days (19 firms in the past year).
Comparing each firm's latest target with its previous one: 8 raised their price target and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Evercore ISI raised its target from $26.00 (set 10 Aug 2026) to $33.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Citizens JMP | Jason N Butler | Buy | 1 Jul 2026 | 35.00 USD |
| Evercore ISI | Gavin Clark-Gartner | Buy | 10 Aug 2026 | 26.00 USD |
| Goldman Sachs | Richard Law | Buy | 30 Jun 2026 | Conflicting reports · excluded |
| H.C. Wainwright | Douglas Tsao | Buy | 6 Aug 2026 | 22.00 USD |
| Jefferies | Faisal Khurshid | Buy | 29 Jun 2026 | 30.00 USD |
| Leerink Partners | Thomas J Smith | Buy | 17 Sep 2026 | 50.00 USD |
| Lifesci Capital | Rami Katkhuda | Buy | 29 Jun 2026 | 35.00 USD |
| Needham | Serge Belanger | Buy | 29 Jun 2026 | Conflicting reports · excluded |
| RBC Capital Markets | Lisa Walter | Buy | 22 Sep 2026 | 38.00 USD |
| Stifel | Unnamed analyst | — | 13 May 2026 | 39.00 USD |
| TD Cowen | Joseph Thome | Buy | 6 Jan 2026 | — |
| Truist | Gregory Renza | Buy | 7 Aug 2026 | 39.00 USD |
| UBS | Michael J Yee | Buy | 7 Aug 2026 | 50.00 USD |
| Wedbush | Laura Chico | Buy | 19 Oct 2026 | 41.00 USD |
| Weiss Ratings | Unnamed analyst | — | 14 Sep 2026 | — |
| Wells Fargo | Derek Archila | Buy | 29 Jun 2026 | 31.00 USD |
| William Blair | Lachlan Hanbury-Brown | Buy | 13 Oct 2026 | 47.00 USD |
| Wolfe Research | Andy G Chen | Buy | 5 Aug 2026 | 32.00 USD |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:53 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.